Italy· 043030030
INCRESYNC*28 cpr rivestite 12,5 mg + 30 mg
A pioglitazone and alogliptin product containing alogliptin/pioglitazone, registered in Italy by TAKEDA PHARMA A/S, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Pioglitazone and alogliptin is registered in 9 of 19 countries.
Countries holding a registration under ATC A10BD09 (pioglitazone and alogliptin), each read from that country’s own register.
- This record: Italy
- 6 of them publish a price we can compare per daily dose
Pioglitazone and alogliptin · ATC A10BD09
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
The record
At a glance
- Active substance
- Alogliptin/Pioglitazone
- Manufacturer
- TAKEDA PHARMA A/S
- Country
- Italy (IT)
- ATC code
- A10BD09
- ATC class
- Pioglitazone and alogliptin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic043030030INCRESYNC*28 cpr rivestite 12,5 mg + 30 mgEUR 55.87
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BD09
Pioglitazone and alogliptin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3ca4f65-5ac2-437c-bd8c-a7252bca007f GET /v1/drugs/b3ca4f65-5ac2-437c-bd8c-a7252bca007f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 55.87,
"source": "aifa",
"currency": "EUR",
"strength": "ALOGLIPTIN+PIOGLITAZONE 12,5MG+30MG 28 UNITA' USO ORALE",
"substance": "Alogliptin/Pioglitazone",
"equivalence_group": "GYU",
"transparency_flag": null
}See everything about pioglitazone and alogliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.